Pharmafile Logo
Pharmafocus logo
Advanced Search
red_consultancy_sarah_mckinnon_clark

Sarah McKinnon Clark joins the Red Consultancy

May 20, 2011
Medical Communications appointment, medical communications

The Red Consultancy has hired Sarah McKinnon Clark as an account manager for its specialist health team Red Health. She …

Appointment

Shire promotional magnet attracts FDA wrath

May 20, 2011
Medical Communications, Sales and Marketing FDA, Shire

The use of a promotional magnet by marketers at Shire has attracted trouble from the FDA. The magnet, which is …

News
GlaxoSmithKline

GSK takes lead role in UK personalised medicine programme

May 20, 2011
Research and Development AstraZeneca, GlaxoSmithKline, Ig Innovations, Janssen, Randox Laboratories, personalised medicine

The first cheque has been written for the government-backed Stratified Medicine Innovation Platform (SMIP), set up last year to pump …

News

Pfizer’s cancer drug meets end points in head-to-head study

May 20, 2011
Research and Development, Sales and Marketing Pfizer, axitinib, rcc

Pfizer’s investigational cancer drug axitinib significantly increased survival in kidney cancer patients when compared to Bayer’s standard treatment Nexavar. New …

News

Stephen Dorrell: Health reforms need wider focus

May 19, 2011
Health and Social Care Bill, NHS reforms

The government’s radical reform of the NHS must focus on integrated care and not just GPs, according to the chairman …

Feature

Blood cancer charity to kick-start clinical trials

May 19, 2011
Research and Development Cancer, blood cancer, clinical trials, leukaemia

A UK blood cancer charity is creating a network of clinical trial centres with backing from the NIHR Clinical Research …

News
Roche

MetMab produces exciting results in lung cancer patients

May 19, 2011
Research and Development MetMAb, Roche

Roche’s MetMab has shown huge promise in phase II trials in lung cancer – but only in patients with ‘high …

News
Takeda headquarters

Takeda buys Nycomed for $13.6bn

May 19, 2011
Manufacturing and Production, Research and Development, Sales and Marketing Nycomed, Takeda

Takeda has acquired Swiss specialist pharma firm Nycomed, boosting its presence in emerging markets. The deal comes in at 9.6 …

News

Patheon appoints Michael Lytton

May 19, 2011
Manufacturing and Production appointment, manufacturing and production

Canadian contract manufacturer Patheon has appointed Michael Lytton as executive VP, corporate development and strategy, and general counsel. He moves …

Appointment

Digital media – spreading the word on Return on Investment

May 19, 2011
Medical Communications, Sales and Marketing ROI, digital marketing

The rise of digital marketing in the pharma sector has brought renewed focus to tracking effectiveness, because digital is seen …

Feature

Grunenthal in talks to sell pain drug portfolio

May 19, 2011
Sales and Marketing Grunenthal, Stada, chronic pain, pain therapeutics

Grunenthal is negotiating a 360 million euro deal to sell Central and Eastern European rights to some of its pain …

News
dick_dunford_tbwa_paling_walters

TBWA Paling Walters appoints new creative director

May 18, 2011
Medical Communications appointment, medical communications

Dick Dunford has joined UK healthcare communications agency TBWA\ Paling Walters as its executive creative director.  He has over 20 …

Appointment
Merck & Co's Victrelis (boceprevir)

Merck and Roche sign hepatitis C co-promotion deal

May 18, 2011
Medical Communications, Sales and Marketing Merck, Roche, hepatitis C

Merck & Co and Roche have signed an agreement that will see them co-promote each other’s hepatitis C drugs in …

News

Pfizer files lung cancer drug in US and Japan

May 18, 2011
Sales and Marketing NSCLC, Pfizer, crizotinib

Pfizer has submitted its oral lung cancer drug crizotinib for regulatory approval in the US and Japan. Crizotinib is an …

News
Shire UK

Shire makes $750m regenerative medicines acquisition

May 18, 2011
Manufacturing and Production, Research and Development, Sales and Marketing Shire, regenerative medicine

Shire’s ambitions to build a regenerative medicine business will soon be realised following its $750 million acquisition of Advanced BioHealing. …

News

Mark Dean-Netscher joins Penn Pharma

May 18, 2011
Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

Penn Pharma has appointed Mark Dean-Netscher as its new chief operating officer. He has more than 20 years experience in …

Appointment

Prime Minister stands by radical NHS shake up

May 17, 2011
Health and Social Care Bill, NHS reforms

Prime Minister David Cameron is standing firm on the government’s planned restructuring of the NHS despite mounting opposition. Cameron was …

News
Eli Lilly and Company

Lilly accused of anti-competitive practices

May 17, 2011
Amylin, Boehringer, diabetes, exenatide, lilly, linagliptin

Amylin Pharmaceuticals is suing Eli Lilly and Company for alleged anticompetitive activity around Lilly’s January agreement with Boehringer Ingelheim to …

News

Teva plans Japan expansion with Taiyo buy

May 17, 2011
Sales and Marketing Taiyo, Teva, generics

Teva is to acquire a majority stake in Taiyo, Japan’s third largest generics company for $460 million in cash. The …

News
Lonza Visp Switzerland

Lonza invests again in Visp high-potency capacity

May 17, 2011
Manufacturing and Production APIs, HPAPIs, Lonza, manufacturing and production

Lonza has pushed further into the high-potency active pharmaceutical ingredient (HPAPI) sector with another round of investment at its manufacturing …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026